Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant, page-53

You might realise ? - we are nice to other holders in here, and give a lot of respect where is deserved.

Can be joking also, however all in good fun, & with respect generally for all.
Not in hyped way, just respect for others including some medical cohort and the science buffs who post & research; biology & physiology etal.
Good humour grown too through several years.

We have also lost fellow shareholders to cancer, who happen to have sadly been diagnosed in recent years.
If others can hang in -we may have irony of Bisantrene even be able to be used in treatment to hopefully bring a cure, where even this didn’t seem so possible two years ago with the treatments available to them.

Sticking to your line, after people firstly try to humour you, when you are wrong, doesn’t reflect well upon one or make you feel good ultimately. (Denigrating and wildly disrespecting some very highly qualified people. )
Wish you all the best.

Amazing announcement today - the history of Bisantrene is a story that will be told I think.
Unfortunately how difficult the path can frequently be through decades for significant drug success.

Bisantrene is now reformulated for useful contemporary practice by Race , with its well -understood safety profile from its historic use in thousands of patients in many past trials also, as well as recent with RAC- Bisantrene was fully approved in France back in time, before it was lost by Lederle in the series of acquisitions and mergers in the 1990.

Lest we forget also that in France today there are now middle - aged women who were completely cured by last ditch salvage treatment with Bisantrene in 1988/89 and the 1990s, with their relapsed dire acute leukaemia, when they were small children.

Lucky to have been able to successfully receive a bone marrow transplant and also survive this onwards.
They got to grow up, now adults and have 4 children between them- the 2 girls the French doctor has documented and followed through years to see how they survived and fared after their successful miraculous treatment when they had had only months at most to otherwise live.
Many other children also achieved a complete response with Bisantrene to their AML, but didn’t get to receive / survive with an available exact matching and successful bone marrow transplant. This was 1990s still and today would not be an issue if remission achieved, to receive successful now transplant .
It is more incredible, and less likely for childhood cancer survivors in the past 20 years to grow up and be able to longterm have a family of their own, and live ongoing normal lives fully cured still also, after now over 30 years.

This is significant and wonderful to have distinguished now original doctor researcher from Bisantrene past inc notable breast cancer trials- aboard RAC clinical advisory team.